Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The quick ratio (acid-test) is N/A as of Tuesday, October 6, 2026.
QUICK RATIO (ACID-TEST)
N/A
Conexeu Sciences Inc.
Market Cap
$83.49M
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$83.96M
Quick Ratio (Acid-Test)
7.03
TTM Avg
3.05
3Y Avg
3.90
5Y Avg
4.20
Market Cap
$84.70M
Quick Ratio (Acid-Test)
1.98
TTM Avg
0.61
3Y Avg
1.40
5Y Avg
2.59
Market Cap
$84.75M
Quick Ratio (Acid-Test)
7.99
TTM Avg
9.12
3Y Avg
12.06
5Y Avg
14.25
Market Cap
$81.22M
Quick Ratio (Acid-Test)
0.34
TTM Avg
0.10
3Y Avg
0.26
5Y Avg
0.26
Market Cap
$86.69M
Quick Ratio (Acid-Test)
1.01
TTM Avg
1.14
3Y Avg
1.20
5Y Avg
1.25
Market Cap
$87.86M
Quick Ratio (Acid-Test)
3.30
TTM Avg
5.38
3Y Avg
8.10
5Y Avg
12.75
Market Cap
$91.33M
Quick Ratio (Acid-Test)
1.00
TTM Avg
1.24
3Y Avg
1.67
5Y Avg
2.90
Market Cap
$91.68M
Quick Ratio (Acid-Test)
23.40
TTM Avg
7.13
3Y Avg
4.61
5Y Avg
6.59
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | $83.49M | N/A | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $83.96M | 7.03 | 3.05 | 3.90 | 4.20 |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $84.70M | 1.98 | 0.61 | 1.40 | 2.59 |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $84.75M | 7.99 | 9.12 | 12.06 | 14.25 |
| Citius Oncology, Inc. (CTOR)vs › | $81.22M | 0.34 | 0.10 | 0.26 | 0.26 |
| CareCloud, Inc. (CCLD)vs › | $86.69M | 1.01 | 1.14 | 1.20 | 1.25 |
| Cardiff Oncology, Inc. (CRDF)vs › | $87.86M | 3.30 | 5.38 | 8.10 | 12.75 |
| electroCore, Inc. (ECOR)vs › | $91.33M | 1.00 | 1.24 | 1.67 | 2.90 |
| Equillium, Inc. (EQ)vs › | $91.68M | 23.40 | 7.13 | 4.61 | 6.59 |
| Biomea Fusion, Inc. (BMEA)vs › | $93.99M | 3.47 | 4.19 | 5.60 | 16.48 |
Quick Ratio
N/A
Excludes inventory
Current Ratio
N/A
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
